4/A: Celularity Director LeVien Boosts Stake with RSU Grant

Celularity Inc. Director Vincent LeVien acquired 28,847 shares of Class A common stock through an RSU grant, increasing his beneficial ownership to 153,847 shares.

Summary

• Vincent LeVien, a Director of Celularity Inc. (CELU), acquired 28,847 shares of Class A common stock.
• The acquisition was through a grant of Restricted Stock Units (RSUs) under the Celularity Inc. 2021 Equity Incentive Plan.
• Each RSU represents a right to receive one share of Class A common stock and vested immediately upon grant.
• Following this transaction, LeVien beneficially owns a total of 153,847 shares of Class A common stock.
• The transaction date for the RSU grant was January 12, 2026.

Sentiment

Score: 6

Explanation: A director increasing their stake, even through an RSU grant, is generally a positive signal of confidence in the company's future, though it's a routine compensation event.

Positives

• A director increasing their stake in the company, even through an RSU grant, can signal confidence in its future prospects.
• The immediate vesting of the 28,847 RSUs provides direct ownership without a future waiting period, aligning interests.

Future Outlook

The filing does not contain specific forward-looking statements or guidance, as it is a disclosure of an insider transaction.

Industry Context

This Form 4/A filing, detailing an insider stock acquisition, is a routine disclosure for publicly traded companies. It reflects an individual director's equity compensation and ownership changes, rather than broader industry trends or competitive positioning.

Comparison to Industry Standards

• This filing is a standard insider transaction report (Form 4/A) and does not contain information suitable for comparison to industry-specific project results or company performance benchmarks. It solely reports a director's equity compensation and ownership.

Stakeholder Impact

• Shareholders: Increased director ownership may be viewed positively as it aligns management interests with shareholder interests.
• Employees: The grant of RSUs is part of an equity incentive plan, which can motivate and retain key personnel.

Key Dates

Recommendation

This filing is a routine disclosure of an insider's equity compensation (RSU grant) and does not provide sufficient information to change an investment recommendation. While increased insider ownership can be a minor positive signal, it's a standard compensation event and not indicative of a fundamental shift in the company's prospects that would warrant a 'buy' or 'sell' recommendation based solely on this filing.

Keywords

Celularity Inc., CELU, Vincent LeVien, Director, Insider Transaction, Form 4/A, Restricted Stock Units, RSU, Equity Incentive Plan, Stock Grant